{
    "medicine_id": "3cbb899ac3894562946e430be879c8e97d0361ae",
    "platform_id": "DB11640",
    "metadata": {
        "name": "Firdapse 10 mg Tablet",
        "composition": "10 mg Amifampridine",
        "clinical_particulars": {
            "therapeutic_indications": "Amifampridine is indicated for the symptomatic treatment of Lambert Eaton myasthenic syndrome LEMS in adults F272 and in patients aged 6 to less than 17 years of age F4609 L6250 Nevertheless it is important to note that at the current time only the Firdapse brand of amifampridine is indicated for the treatment of LEMS in adults F272 and the Ruzurgi brand of amifampridine is indicated for the treatment of LEMS in patients aged 6 to less than 17 years F4609 L6250",
            "contraindications": {
                "disease": "The approximate oral LD50 was 25mg kg in rats and 100 mg kg in mice The approximate intravenous LD50 was 25 mg kg in both rats and mice F273 Peritoneal and subcutaneous LD50 in mice were 20 mg kg and 35 mg kg respectively A33863 There is limited clinical experienced with amifampridine overdose The manifestations of acute drug overdose may include abdominal pain and should be responded with discontinuation of treatment and initiation of supportive care with close monitoring of viral signs There is no specific antidote known for amifampridine F272 _In vitro_ amifampridine showed no clinically relevant carcinogenic or genotoxic potential However in a 2 year rat study amifampridine caused small but statistically significant dose related increases in the incidence of Schwannomas in both genders and of endometrial carcinomas in females F272 At doses higher than the recommended daily dose for humans amifampridine caused a dose related increase in the percentage of pregnant rats with stillborn offspring F272 Effects on the central and autonomic nervous system increased liver and kidney weights and cardiac effects second degree atrioventricular block were seen in a repeat dose toxicity studies in rats and dogs F272",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Administration of amifampridine to patients with LES in clinical trials resulted in improvement of the compound muscle action potential CMAP muscle function and quantitative myasthenia gravis QMG score A33863 One case of a slight prolongation of the QTc interval in male patient with LEMS and euthyroid Hashimoto s disease treated with 90 mg of amifampridine in combination with 100 mg azathioprine was reported A33863 I_n vitro_ amifampridine was shown to modulate cardiac conduction and induce phasic contractions in different arteries from several species A33863 In addition it stimulated potassium evoked dopamine and noradrenaline release in rat hippocampal slices and upregulate acetylcholine release in the brain A33863 It may also potentiate adrenergic and cholinergic neuromuscular transmission in the gatrointestinal tract A33863 In a single pharmacokinetic study no effect was observed of amifampridine phosphate on cardiac repolarization as assessed using the QTc interval F272 There were no changes in heart rate atrioventricular conduction or cardiac depolarization as measured by the heart rate PR and QRS interval durations F272",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09083",
                        "description": "Ivabradine may increase the QTc prolonging activities of Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Promazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Loperamide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Primaquine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Papaverine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Propafenone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Flecainide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Probucol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Azimilide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Technetium Tc 99m ciprofloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Telavancin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Antazoline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Fendiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Eperisone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Melperone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Benidipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Methadone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Droperidol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Emedastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Amifampridine may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of seizure can be increased when Cyclosporine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of seizure can be increased when Amphetamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of seizure can be increased when Tramadol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of seizure can be increased when Enflurane is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The risk or severity of seizure can be increased when Theophylline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The risk or severity of seizure can be increased when Lidocaine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of seizure can be increased when Venlafaxine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of seizure can be increased when Chlorambucil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The risk or severity of seizure can be increased when Bupivacaine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of seizure can be increased when Amitriptyline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of seizure can be increased when Protriptyline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of seizure can be increased when Mefloquine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of seizure can be increased when Clozapine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of seizure can be increased when Phenylpropanolamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of seizure can be increased when Methylphenidate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of seizure can be increased when Cyproheptadine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of seizure can be increased when Meperidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "The risk or severity of seizure can be increased when Cefalotin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of seizure can be increased when Imipramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of seizure can be increased when Quinine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of seizure can be increased when Chlorpromazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "The risk or severity of seizure can be increased when Cefotaxime is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of seizure can be increased when Nortriptyline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of seizure can be increased when Amoxapine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of seizure can be increased when Linezolid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of seizure can be increased when Chloroquine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of seizure can be increased when Furazolidone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of seizure can be increased when Fluphenazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of seizure can be increased when Dextropropoxyphene is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of seizure can be increased when Pentazocine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of seizure can be increased when Amphotericin B is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of seizure can be increased when Azatadine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of seizure can be increased when Procaine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of seizure can be increased when Trimipramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of seizure can be increased when Risperidone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of seizure can be increased when Tranylcypromine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of seizure can be increased when Isoflurane is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of seizure can be increased when Nalidixic acid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of seizure can be increased when Phenelzine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of seizure can be increased when Minaprine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of seizure can be increased when Fentanyl is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of seizure can be increased when Propofol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of seizure can be increased when Disulfiram is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00902",
                        "description": "The risk or severity of seizure can be increased when Methdilazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of seizure can be increased when Cocaine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of seizure can be increased when Quinidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of seizure can be increased when Metronidazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of seizure can be increased when Cyclobenzaprine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of seizure can be increased when Maprotiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of seizure can be increased when Isoniazid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of seizure can be increased when Ganciclovir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of seizure can be increased when Selegiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01061",
                        "description": "The risk or severity of seizure can be increased when Azlocillin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of seizure can be increased when Promethazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of seizure can be increased when Pimozide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of seizure can be increased when Sertraline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of seizure can be increased when Doxepin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of seizure can be increased when Desipramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of seizure can be increased when Bupropion is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of seizure can be increased when Moclobemide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of seizure can be increased when Halofantrine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The risk or severity of seizure can be increased when Aminophylline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of seizure can be increased when Clomipramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of seizure can be increased when Isocarboxazid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of seizure can be increased when Rasagiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01598",
                        "description": "The risk or severity of seizure can be increased when Imipenem is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "The risk or severity of seizure can be increased when Valganciclovir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of seizure can be increased when Pargyline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB02136",
                        "description": "The risk or severity of seizure can be increased when Cephalosporin analog is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB03313",
                        "description": "The risk or severity of seizure can be increased when Cephalosporin C is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB03938",
                        "description": "The risk or severity of seizure can be increased when Deacetoxycephalosporin C is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of seizure can be increased when Iproniazid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of seizure can be increased when Nialamide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of seizure can be increased when Amineptine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of seizure can be increased when Safinamide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of seizure can be increased when Desvenlafaxine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of seizure can be increased when Fospropofol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06793",
                        "description": "The risk or severity of seizure can be increased when Levopropoxyphene is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of seizure can be increased when Dimetacrine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of seizure can be increased when Butriptyline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of seizure can be increased when Dosulepin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of seizure can be increased when Methylene blue is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of seizure can be increased when Hydracarbazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of seizure can be increased when Pirlindole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of seizure can be increased when Toloxatone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of seizure can be increased when Benmoxin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of seizure can be increased when Mebanazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of seizure can be increased when Octamoxin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of seizure can be increased when Pheniprazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of seizure can be increased when Phenoxypropazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of seizure can be increased when Pivhydrazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of seizure can be increased when Safrazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of seizure can be increased when Caroxazone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of seizure can be increased when Tianeptine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of seizure can be increased when Oxaprotiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The risk or severity of seizure can be increased when Sodium phosphate monobasic is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of seizure can be increased when Dexchlorpheniramine maleate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11199",
                        "description": "The risk or severity of seizure can be increased when Sage oil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11238",
                        "description": "The risk or severity of seizure can be increased when Borage oil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "The risk or severity of seizure can be increased when Evening primrose oil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11447",
                        "description": "The risk or severity of seizure can be increased when Phenothiazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of seizure can be increased when Opipramol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of seizure can be increased when Amitriptylinoxide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of seizure can be increased when Dibenzepin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of seizure can be increased when Quinupramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of seizure can be increased when Melitracen is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of seizure can be increased when Lofepramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of seizure can be increased when Iprindole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of seizure can be increased when Dexchlorpheniramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of seizure can be increased when Imipramine oxide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13854",
                        "description": "The risk or severity of seizure can be increased when Gamolenic acid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of seizure can be increased when Harmaline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB14071",
                        "description": "The risk or severity of seizure can be increased when Desmethylsertraline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01362",
                        "description": "The risk or severity of seizure can be increased when Iohexol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB14256",
                        "description": "The risk or severity of seizure can be increased when Centella asiatica is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The risk or severity of adverse effects can be increased when Pegvisomant is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The risk or severity of adverse effects can be increased when Tacrine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when Sulpiride is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The risk or severity of adverse effects can be increased when Profenamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Triflupromazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Cisplatin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00527",
                        "description": "The risk or severity of adverse effects can be increased when Cinchocaine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00545",
                        "description": "The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The risk or severity of adverse effects can be increased when Nizatidine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of adverse effects can be increased when Galantamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00677",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurophate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00711",
                        "description": "The risk or severity of adverse effects can be increased when Diethylcarbamazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of adverse effects can be increased when Terbutaline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Hexafluronium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00944",
                        "description": "The risk or severity of adverse effects can be increased when Demecarium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00981",
                        "description": "The risk or severity of adverse effects can be increased when Physostigmine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "The risk or severity of adverse effects can be increased when Rivastigmine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "The risk or severity of adverse effects can be increased when Edrophonium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of adverse effects can be increased when Procainamide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The risk or severity of adverse effects can be increased when Memantine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01122",
                        "description": "The risk or severity of adverse effects can be increased when Ambenonium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Tubocurarine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Ketamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of adverse effects can be increased when Metoclopramide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Decamethonium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Pancuronium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Pipecuronium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01400",
                        "description": "The risk or severity of adverse effects can be increased when Neostigmine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of adverse effects can be increased when Bambuterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB02365",
                        "description": "The risk or severity of adverse effects can be increased when 1 10 Phenanthroline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of adverse effects can be increased when Thiotepa is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04864",
                        "description": "The risk or severity of adverse effects can be increased when Huperzine A is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB04892",
                        "description": "The risk or severity of adverse effects can be increased when Phenserine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB05386",
                        "description": "The risk or severity of adverse effects can be increased when Regramostim is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "The risk or severity of adverse effects can be increased when Aprotinin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06756",
                        "description": "The risk or severity of adverse effects can be increased when Glycine betaine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The risk or severity of adverse effects can be increased when Capsaicin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of adverse effects can be increased when Coumaphos is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of adverse effects can be increased when Dichlorvos is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of adverse effects can be increased when Fenthion is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11473",
                        "description": "The risk or severity of adverse effects can be increased when Metrifonate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12482",
                        "description": "The risk or severity of adverse effects can be increased when Acotiamide is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13058",
                        "description": "The risk or severity of adverse effects can be increased when Methanesulfonyl Fluoride is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13495",
                        "description": "The risk or severity of adverse effects can be increased when Paraoxon is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13503",
                        "description": "The risk or severity of adverse effects can be increased when Tyrothricin is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13668",
                        "description": "The risk or severity of adverse effects can be increased when Ipidacrine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB13694",
                        "description": "The risk or severity of adverse effects can be increased when Distigmine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "The risk or severity of adverse effects can be increased when Tretamine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB15317",
                        "description": "The risk or severity of adverse effects can be increased when Posiphen is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB02845",
                        "description": "The risk or severity of adverse effects can be increased when Methylphosphinic Acid is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Amifampridine may increase the QTc prolonging activities of Pitolisant"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Amifampridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}